The two products, both manufactured by Amgen, are aflibercept biosimilars Pavblu and Skojoy. Both biosimilars are indicated ...
A South Korean appeals court cleared Samsung Electronics Chair Lee Jae-yong Monday of stock manipulation and accounting fraud ...
Hankyoreh on MSN1d
Appeals court upholds acquittal of Samsung’s Lee in 2015 merger caseLike the lower court, the appeals court did not accept prosecutors’ evidence of accounting fraud as admissible ...
THE CHOSUNILBO on MSN2d
Samsung Chairman Lee Jae-yong cleared of all charges in 2015 merger caseSamsung Electronics Chairman Lee Jae-yong was acquitted in an appellate trial on Feb. 3, clearing him of stock manipulation ...
On January 29, 2025, the Federal Circuit issued paired decisions addressing Samsung Bioepis’s (“SB”) and Formycon AG’s ...
The Federal Circuit left in place a pair of orders blocking two competitors of Regeneron Pharmaceuticals Inc. from marketing ...
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., Appeal Nos. 2024-1965, -1966, -2082, -2083 (Fed. Cir. Jan. 29, 2025) ...
The South Korean firm just agreed to buy Biogen out of their biosimilar joint venture – Samsung Bioepis – for $2.3 billion. The two companies have been partnered on Samsung Bioepis for the ...
The FDA accepted applications for a golimumab biosimilar, while Samsung Biologics reported record sales, and a Japanese ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback